![[LSUK] Life-Sciences-UK.com - The UK Life Sciences Web Portal](/images/basics/lsuk-life-sciences-uk-portal-logo.svg){kind=logo}
Advertisement
All
>
Persons > United Kingdom (GB)
Please find below persons from the United Kingdom (GB) or related to British organisations.Total search results: 2831 | Ordered by Region (ascending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 
  Person |
Position |
Organisation (Group) |
 Region |
|---|---|---|---|
| Kirby, Pamela (Oxford Immunotec 200412– Chairman before Quintiles Transnational Corp CEO) | Board member | Oxford Immunotec (Group) | South East England (region) |
| Kirkman, Crispin (Theryte 201201 CBO before ETNA + NHS) | Chief Business Officer (CBO) | Theryte Ltd. | South East England (region) |
| Knight, Steve (Porvair Sciences 201201 Director of Sales + Marketing) | Sales Manager / Marketing Manager | Porvair (Group) | South East England (region) |
| Knowles, David (Piramed 200503– CSO before RiboTargets + British Biotech) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Roche (Group) | South East England (region) |
| Koski, Karen (Oxford Immunotec 201706– Head of Strategy + Investor Relations) | Business Development Manager / Strategy Manager | Oxford Immunotec (Group) | South East England (region) |
| Kramer, Ann (Oxitec 200610 Head Business Development) | Business Development Manager / Strategy Manager | Third Security (Randal J. Kirk) (Group) | South East England (region) |
| Kramer, Mark (GE Healthcare 200704– VP before FDA) | n. a. | General Electric (Group) | South East England (region) |
| Kuhlman, Helen (Chronos Therapeutics 201607 VP Corporate Development) | Business Development Manager / Strategy Manager | Chronos Therapeutics Ltd. | South East England (region) |
| Kumagai, Akihiko (General Electric 201411 Chairman of GE Healthcare Japan) | President/Director/Head Business Group/Unit/Division | General Electric (Group) | South East England (region) |
| Lamble, Harry (Sense Biodetection 202104 CEO) | Chief Executive Officer (CEO) | Sherlock Biosciences (Group) | South East England (region) |
| Langhorst, Matthias (Refeyn 202308 Chief Product Officer) | Product Manager (personnel) | Refeyn (Group) | South East England (region) |
| Langley, G. John (Univ Southampton 201005 Head Mass Spectrometry) | Head Mass Spectrometry / NMR Laboratory (university / research institute) | University of Southampton | South East England (region) |
| Laskow-Pooley, David (OBN 201506 Chairman) | Board member | OBN (UK) Ltd. | South East England (region) |
| Laskow-Pooley, David (Surface Therapeutics 200501 CEO) | Chief Executive Officer (CEO) | Serentis (Group) | South East England (region) |
| Law, Richard (Exscientia 202101– EVP Strategic Alliances before Evotec + UCSD + LLNL) | Business Development Manager / Strategy Manager | Exscientia (Group) | South East England (region) |
| Lawson, Stuart (Centauri Therapeutics 201604 CFO) | Chief Financial Officer (CFO) | Centauri Therapeutics Ltd. | South East England (region) |
| Le Chat, Chantal (General Electric 201111 General Manager GE Healthcare Interventional Radiology) | General Manager (management) | General Electric (Group) | South East England (region) |
| Leavenworth-Bakali, Staph (George Institute 201807 CEO of George Health Enterprises) | Chief Executive Officer (CEO) | George Institute for Global Health, The | South East England (region) |
| Lee, Steven (VASTox 200701 CEO) | Chief Executive Officer (CEO) | Summit (Group) | South East England (region) |
| Lees, Mark (T-Cypher Bio 202107 VP Corporate Development + Strategy) | Business Development Manager / Strategy Manager | T-Cypher Bio Ltd. | South East England (region) |
| Lernbecher, Thomas (4titude Ltd 201710 Co-Founder) | Company Founder | Azenta (Group) | South East England (region) |
| Leslie, Carol (Andrew Lloyd & Associates 201509) | public relations / investor relations | Andrew Lloyd & Associates (ALA) | South East England (region) |
| Linn, Stefan (Oxford Immunotec 201708– COO before IMS Health Holdings + TPG Capital + McKesson Corp + Merck-Medco) | Chief Operating Officer (COO) | Oxford Immunotec (Group) | South East England (region) |
| Litivnov, Sergey (Aptum Biologics 202102 CEO) | Chief Executive Officer (CEO) | Aptum Biologics Ltd. | South East England (region) |
| Llewellyn, David (DJS Antibodies 202210 CEO + Co-Founder) | Chief Executive Officer (CEO) | AbbVie (Group) | South East England (region) |
| Llobet, Manuel (Allergy Therapeutics 201709 CEO) | Chief Executive Officer (CEO) | Allergy Therapeutics (Group) | South East England (region) |
| Lloyd, Andrew (Andrew Lloyd & Associates) | Company Founder | Andrew Lloyd & Associates (ALA) | South East England (region) |
| Loeffen, Paul (Cobalt Light Systems 201707 CEO before Oxford Diffraction 200804 CEO) | Chief Executive Officer (CEO) | Agilent (Group) | South East England (region) |
| Logue, Fraser (Lab21 201202– Group Director Quality, Regulatory Affairs & Operations Excellence before Abbott) | Regulatory Affairs Manager | Novacyt (Group) | South East England (region) |
| Loke, Hsin (OMass 201811– VP Head of Finance + Strategy before 16 years at GSK) | Chief Financial Officer (CFO) | OMass Therapeutics Ltd. | South East England (region) |
| Long, Ron (Procognia 200501 CEO before Amersham 199008–200106 incl CEO 1997–200006) | Chief Executive Officer (CEO) | Procognia (Group) | South East England (region) |
| Lowther, Susan (Lab21 –201207–201409 CFO LEFT 9/14) | Chief Financial Officer (CFO) | Novacyt (Group) | South East England (region) |
| Lubroth, Pablo (Midven 202004 Investment Manager at UKI2S) | Investment Manager | Future Planet Capital (Group) | South East England (region) |
| Lundin, Per (Evox Therapeutics 201711– COO before acting CEO + Co-Founder) | Chief Operating Officer (COO) | Evox Therapeutics Ltd. | South East England (region) |
| MacKay, Gerry (Refeyn 202401– CEO before Sartorius + Millipore + BioOutsource) | Chief Executive Officer (CEO) | Refeyn (Group) | South East England (region) |
| MacKinnon, Lachlan T. (Landsdowne Partners 202112 Representative before Oxford Univ 202002 Principal at OSI) | Principal (venture capital) | Oxford Science Enterprises (Group) | South East England (region) |
| Macpherson, Ian (Oxford Science Park 201105 Business Development Manager) | Business Development Manager / Strategy Manager | University of Oxford | South East England (region) |
| Mallinson, James (Oxford Univ 201805 Partner at Oxford Investment Consultants) | Partner (venture partner) | Oxford Science Enterprises (Group) | South East England (region) |
| Malthouse, James (Proteome Sciences 201006 Finance Director) | Chief Financial Officer (CFO) | Proteome Sciences (Group) | South East England (region) |
| Marchington, Tony (Avacta 201103 CEO of Oxford Medical Diagnostics) | Chief Executive Officer (CEO) | Avacta (Group) | South East England (region) |
| Martin, Stuart (United Kingdom (govt) 201905 CEO of Satellite Applications Catapult) | Chief Executive Officer (CEO) | United Kingdom (GB) (govt) | South East England (region) |
| Mathias, Frank (Oxford Biomedica 202203– CEO before Rentschler + Medigene + Amgen GmbH + Servier DE + Hoechst) | Managing Director | Oxford Biomedica (Group) | South East England (region) |
| Matthews, Kevin (Oxonica 200507 CEO) | Chief Executive Officer (CEO) | Oxonica plc | South East England (region) |
| Maw, Rory (Univ Oxford 202207 CEO of The Oxford Science Park) | Chief Executive Officer (CEO) | University of Oxford | South East England (region) |
| Mazzon, Michela (Virology Research Services 202201 Managing Director + Co-Founder) | Managing Director | Virology Research Services Ltd. (VRS) | South East England (region) |
| McCarthy, Kirsty (Pathios Therapeutics 201904) | n. a. | Pathios Therapeutics Ltd. | South East England (region) |
| McCarthy, Thomas David (Tom) (Grey Wolf Therapeutics 201902 Executive Chairman + Co-Founder before CEO of Spinifex) | Board member, executive | Grey Wolf Therapeutics Ltd. | South East England (region) |
| McDonald, Mike (Oxford BioMedica 200509–200808 CEO before CMO before Seattle Genetics CMO) | Chief Executive Officer (CEO) | Oxford Biomedica (Group) | South East England (region) |
| McGettrick, Aileen (Psyros Diagnostics 202201 Director + Co-Founder before Novartis NPTU/Vivacta) | Board member, executive | Prolight Diagnostics (Group) | South East England (region) |
| McKaig, Brian (GE Healthcare 200612 PR Manager) | n. a. | General Electric (Group) | South East England (region) |
| McKay, Stuart (Hichrom 201006 Managing Director) | Managing Director | Hichrom Ltd. | South East England (region) |
| McKemey, Andrew (Oxitec 200610 Business Development) | Business Development Manager / Strategy Manager | Third Security (Randal J. Kirk) (Group) | South East England (region) |
| McLean, Andrew (Univ Oxford 201906 Head of Life Sciences 201712 Principal at Oxford Sciences Innovation) | IP Manager | Oxford Science Enterprises (Group) | South East England (region) |
| McNeill, John (Phlexglobal 201901– CEO before Sparta Systems + IRI + BravoSolution + VerticalNet) | Chief Executive Officer (CEO) | Phlexglobal (Group) | South East England (region) |
| McVean, Gil (Univ Oxford 202003 Professor + Founding Director of Big Data Institute + 202003– CIO at Genomics plc) | Professor | University of Oxford | South East England (region) |
| Medlicott, Steve (e-Therapeutics 201404– Finance Director) | Chief Financial Officer (CFO) | e-Therapeutics plc (AIM: ETX) | South East England (region) |
| Megit, Stephen (Steve) (Immunocore 201612– Business Development Manager) | Business Development Manager / Strategy Manager | Immunocore (Group) | South East England (region) |
| Mellor, Dee (GE Healthcare 200610) | n. a. | General Electric (Group) | South East England (region) |
| Mencarelli, Chiara (Virology Research Services 202201 Managing Director + Co-Founder) | Managing Director | Virology Research Services Ltd. (VRS) | South East England (region) |
| Merchant, Zahra (Image Box 201310) | Public Relations Manager / Investor Relations Manager | Image Box Ltd. (Image Box PR / IB Communications) | South East England (region) |
| Metcalf, Bevan John (Microsaic 201512– Finance Director before Beowulf Mining + Afferro + African Eagle + Orion + GSK) | Chief Financial Officer (CFO) | Microsaic Systems plc (AIM: MSYS) | South East England (region) |
| Millar, Andy (OGT –200201 CEO of OGT operational business) | Chief Executive Officer (CEO) | Sysmex (Group) | South East England (region) |
| Millen, Jim S. (Physiomics 201906 CEO) | Chief Executive Officer (CEO) | Physiomics plc (AIM: PYC) | South East England (region) |
| Miller, Juli P. (Adaptimmune 201808 Director Investor Relations) | Public Relations Manager / Investor Relations Manager | Adaptimmune (Group) | South East England (region) |
| Miller, Karen (Adaptimmune 201904– SVP Piepline Research before GSK + UCB Pharma + Vertex) | n. a. | Adaptimmune (Group) | South East England (region) |
| Miller, Robert (Phynova Group 200611 CEO) | Chief Executive Officer (CEO) | Phynova (Group) | South East England (region) |
| Millington, Darren (Vastox 200701 CFO) | Chief Financial Officer (CFO) | Summit (Group) | South East England (region) |
| Mills, Tony (Glide Pharma 201407– Director BusDev before Q Chip + BioVex + BTG) | Business Development Manager / Strategy Manager | Glide Pharmaceutical Technologies Ltd. | South East England (region) |
| Mitchell, Jim (GE Healthcare 200808 General Manager Molecular Imaging) | n. a. | General Electric (Group) | South East England (region) |
| Mitrophanous, Kyriacos (Oxford BioMedica 201710 CSO + BIA Board Member) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Oxford Biomedica (Group) | South East England (region) |
| Moffatt, Miriam (Wellcome Trust Centre for Human Genetics 200507) | n. a. | University of Oxford | South East England (region) |
| Monaghan, Paul (Psyros Diagnostics 202201 Head of Engineering + Co-Founder before Novartis NPTU/Vivacta) | Chief Technology/Technical Officer (CTO) | Prolight Diagnostics (Group) | South East England (region) |
| Moon, Stephen (Provexis 200808 CEO) | Chief Executive Officer (CEO) | Provexis (Group) | South East England (region) |
| Moore-Thornicroft, Storme (Emergex Vaccines 202011 COO + Co-Founder) | Chief Operating Officer (COO) | Emergex (Group) | South East England (region) |
| Morgan, Geraint (Agilent 201105 Centre Director Agilent Centre of Excellence in Comprehensive Chromatography UK) | Laboratory Manager (industry) | Open University, The | South East England (region) |
| Morgan, Sarah (Andrew Lloyd Associates 201411) | Public Relations Manager / Investor Relations Manager | Andrew Lloyd & Associates (ALA) | South East England (region) |
| Morley, Trish (BioDot 201107 Office Manager BioDot Ltd) | Commercial Manager_oo | BioDot (Group) | South East England (region) |
| Morris, Charles (Charlie) (PsiOxus 201609– CDO based in US before ImmunoGen + Allos + Cephalon + AstraZenca) | Board member, executive | Akamis Bio (Group) | South East England (region) |
| Morris, Howard R. (M-Scan 1997– founder + Imperial College London Prof) | Company Founder | SGS (Group) | South East England (region) |
| Morton, Bryan (EUSA Pharam 200703 CEO) | Chief Executive Officer (CEO) | Recordati (Group) | South East England (region) |
| Mosejeva, Ilona (Image Box 201511– Junior Account Executive) | n. a. | Image Box Ltd. (Image Box PR / IB Communications) | South East England (region) |
| Moseley, Richard (Microsaic 201309 Product Manager) | Product Manager (personnel) | Microsaic Systems plc (AIM: MSYS) | South East England (region) |
| Moss, Parker (Exscientia 202401– EPV Corporate Development before Genomics England + F-Prime + Eight Roads) | Business Development Manager / Strategy Manager | Exscientia (Group) | South East England (region) |
| Mott, David (Oxford Capital Partners 200504) | Investment Manager | Oxford Capital Partners | South East England (region) |
| Muir, Nicki (Alto Marketing 200810) | Public Relations Manager / Investor Relations Manager | Alto Marketing Ltd. | South East England (region) |
| Muirhead, Gary (Ixchelsis Ltd 201308 CEO) | Chief Executive Officer (CEO) | Ixchelsis Ltd. | South East England (region) |
| Mullen, Greg (Ariceum Therapeutics 202306– COO before Theragnostics CEO) | Chief Executive Officer (CEO) | Ariceum Therapeutics (Group) | South East England (region) |
| Murphy, Graham (Remote Diagnostic Technologies 201806) | Chief Executive Officer (CEO) | Philips (Group) | South East England (region) |
| Neubauer, Stefan (Univ Oxford 201304 Prof + Non-executive Director of Perspectum Diagnostics) | Professor | University of Oxford | South East England (region) |
| Newland, Andrew (Angle plc 201409 CEO + Founder) | Chief Executive Officer (CEO) | Angle plc (AIM: AGL) | South East England (region) |
| Nicholl, Colin (Microsaic 201307–201701 Board Chairman before Deputy Chairman RETIRED 1/17) | Board member, non-executive | Microsaic Systems plc (AIM: MSYS) | South East England (region) |
| Nielsen, Debra (Immunocore 202102 Head of Communications) | Public Relations Manager / Investor Relations Manager | Immunocore Holdings plc (Nasdaq: IMCR) | South East England (region) |
| Noble, James (Adaptimmune 201909– Non-Executive Director before CEO before MediGene + Avidex) | Board member, non-executive | Adaptimmune (Group) | South East England (region) |
| Nolan, Peter (Oxford BioMedica 200507) | n. a. | Oxford Biomedica (Group) | South East England (region) |
| Noonan, Mo (Mo PR Advisory 202005– Founder before 21y at FTI Consulting) | Public Relations Manager / Investor Relations Manager | Mo PR Advisory Ltd. | South East England (region) |
| Northage, Alan (Shimadzu 201112 Shimadzu UK GC/GCMS Business Manager) | Product Manager (personnel) | Shimadzu (Group) | South East England (region) |
| Osborne, Stephen (Pastel BioScience 201509 CEO + CSO + Founder) | Chief Executive Officer (CEO) | Pastel BioScience Ldt. | South East England (region) |
| Owen, David (200510– Board Non-Exec OGT) | Board member, non-executive | Sysmex (Group) | South East England (region) |
| Oxlade, David (Xenova 200504 CEO) | Chief Executive Officer (CEO) | Auven Therapeutics (Group) | South East England (region) |
| O’Higgins, John (Spectris 201801 CEO) | Chief Executive Officer (CEO) | Spectris (Group) | South East England (region) |
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
